Chronic refractory dyspnoea: Evidence based management

Australian Family Physician

Volumn 42, Issue 3, 2013, Pages 137-140

  Wiseman, Rachel ^a   Rowett, Debra ^b,c   Allcroft, Peter ^b   Abernethy, Amy ^d   Currow, David ^e  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c The Department of Veterans' Affairs   (Australia)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Dyspnoea; Heart failure; Lung diseases; Neoplasms; Palliative care

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MORPHINE;

ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEGENERATIVE DISEASE; DYSPNEA; HEART FAILURE; HUMAN; INTERSTITIAL LUNG DISEASE; OXYGEN THERAPY; QUALITY OF LIFE; WALKING;

BENZODIAZEPINES; CHRONIC DISEASE; DYSPNEA; HEART FAILURE; HUMANS; LUNG DISEASES, INTERSTITIAL; MORPHINE; NEURODEGENERATIVE DISEASES; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; WALKING;

EID: 84875515140     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dudgeon D, Lertzman M. Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998;16:212-9.
2. B ruera E, Schmitz B, Pither J, Neumann CM, Hanson J. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000;19:357-62.
3. Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage 2001;21:373-9.
4. Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP. Do the trajectories of dyspnoea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010;39:680-90.
5. Bausewein C, Booth S, Gysels M, Kühnbach R, Haberland B, Higginson IJ. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010;13:1109-18.
6. Johnson M, Bowden J, Abernethy AP, Currow DC. To what clinical causes do patients attribute their breathlessness? A population survey. J Palliat Med 2012;15:744-50.
7. Luddington L, Cox S, Higginson I, Livesley B. The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs 2001;7:221-6.
8. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-8.
9. Nici L, Donner C, Wouters E, et al. American Thoracic Society. Dyspnoea - mechanisms, assessment, and management: A Consensus Statement. Am J Respir Crit Care Med 1999;159:321-40.
10. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008;(2):CD005623.
11. Lacasse Y, Goldstein R, Lasserson T, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;(4):CD003793.
12. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(10):CD005305.
13. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnea. Thorax 2002;57:939-44.
14. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435-52.
15. Qaseem A, Snow V, Shekelle P, Casey DE Jr, Cross JT Jr, Owens DK. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Inter Med 2008;148:141-6.
16. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42:388-99.
17. Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids. J Palliat Med 2008;11:204-16.
18. Currow DC, Abernethy AP, Frith P. Morphine for management of refractory dyspnoea. BMJ 2003;327:1288-9.
19. Ander DS, Aisiku IP, Ratcliff JJ, Todd KH, Gotsch K. Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful. Congest Heart Fail 2004;10:188-91.
20. Karras DJ, Sammon ME, Terregino CA, Lopez BL, Griswold SK, Arnold GK. Clinically meaningful changes in quantitative measures of asthma severity. Acad Emerg Med 2000;7:327-34.
21. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD: J Chronic Obstr Pul Dis 2005;2:105-10.
22. Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(6):CD006429.
23. Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Canc 2008;98:294-9.
24. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind randomized controlled trial (NCT00327873). Lancet 2010;376:784-93.
25. Bushunow PW, Roscoe JA, Dudgeon DJ, et al. Buspirone treatment of dyspnea in outpatients receiving chemotherapy: A University of Rochester Cancer Center Community Clinical Oncology Program (URCC CCOP) study. J Clin Oncol 2011;29(15 Suppl):9023.
26. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and nonmalignant diseases in adults. Cochrane Database Syst Rev 2010;(1):CD007354.